Recent Publications
Global Burden of Anorexia Nervosa and Bulimia Nervosa, 1990 to 2023, With Forecasts to 2050: A Global Burden of Disease Study 2023 Analysis
Wednesday, October 28, 2026
CONCLUSIONS AND RELEVANCE: This GBD 2023 analysis found that anorexia nervosa and bulimia nervosa contribute substantially to global nonfatal health loss. These findings support the integration of eating disorders into mental health surveillance, prevention, and service planning worldwide.
The rise of reducing reagent-resistant TfR1 dimer marks ferroptosis
Thursday, October 22, 2026
Ferroptosis is an iron-dependent type of cell death caused by excessive membrane lipid peroxidation. It remains a challenge to detect ferroptotic cells, especially in in vivo settings, hindering translational studies. Here we discover that a reducing reagent-resistant (3R) dimer of the transferrin receptor 1 (TfR1) is a highly specific indicator for lipid peroxidation. The 3R dimer is elevated in cells when ferroptosis is induced, either by pharmacological agents or by genetic perturbations....
Suicide-Related Responses From AI Chatbots Through Application Programming Interfaces and Consumer-Facing Apps: Observational Cross-Sectional Comparative Study
Friday, October 9, 2026
CONCLUSIONS: AI safety depends on how users access the model. Safety observed in a UI should not be assumed to generalize to API access or apps built on APIs. Evaluations and policies should consider access modes to ensure safety protections for individuals interacting with AI chatbots.
Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023
Wednesday, September 30, 2026
CONCLUSIONS AND RELEVANCE: Heart failure is a significant global public health burden, and the impact is likely to increase as populations age. However, most HF etiologies can be prevented by interventions that reduce exposure to modifiable risk factors, such as elevated blood pressure, excessive alcohol consumption, and tobacco use. Etiology- and location-specific estimates can provide necessary information for public health officials to determine how best to prioritize interventions to reduce...
Women with a history of gestational diabetes mellitus have preserved sensory nerve-mediated dilatation in the cutaneous microvasculature
Wednesday, September 23, 2026
Women with a history of gestational diabetes mellitus (GDM) have a greater risk of developing type 2 diabetes mellitus and cardiovascular disease than healthy control (HC) women who had an uncomplicated pregnancy. Microvascular endothelial dysfunction, mediated by reduced nitric oxide (NO)-dependent mechanisms, persists after GDM. However, it is unknown whether cutaneous sensory nerve-mediated dilatation is similarly reduced in these women. We hypothesised that women with a history of GDM would...
Global burden of disease attributable to unsafe sex among adults aged 60 years and older, 1990-2023: a secondary analysis of the global burden of disease study 2023
Wednesday, September 23, 2026
CONCLUSIONS: Unsafe sex remains a substantial burden among older adults, with increasing absolute burden despite modest declines in age-standardised rates. HIV/AIDS contributed increasingly, although cervical cancer remained the largest contributor in 2023. Population growth was the predominant driver, highlighting the need for life-course prevention and disease-control strategies for healthy ageing.
Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
Monday, September 7, 2026
BACKGROUND: Second-hand smoke (SHS) exposure remains a major source of morbidity and mortality among non-smokers. This study presents the first dedicated Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) publication to systematically quantify SHS prevalence and evaluate its effect as a global risk factor across a broader range of outcomes.
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial
Thursday, August 27, 2026
BACKGROUND: High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6, known as double-hit lymphoma, is a highly aggressive malignancy with poor outcomes after standard chemoimmunotherapy. We aimed to study whether the addition of the BCL2-inhibitor venetoclax to chemoimmunotherapy in patients with double-hit lymphoma resulted in superior efficacy compared with chemotherapy alone.
Sleep Health, Perceived Stress, and Urinary Incontinence Severity Among Women Veterans in the USA
Wednesday, August 19, 2026
CONCLUSION: Sleep health may be a modifiable factor for improving UI-related outcomes, with stress as a potentially relevant contextual factor.